The concept of personalised medicine is not new, but in an era when blockbuster medicines are disappearing, the focus on targeting treatment regimens based on individual patient characteristics is becoming increasingly important. In the August edition of International Clinical Trials, James Sawyer reviews progress in personalised medicine to date and discusses the tools that need to be developed and implemented to provide treatment strategies with greater effectiveness and less toxicity that are also cost effective.
Read the article.
